Person:
KARAASLAN, KAZıM

Loading...
Profile Picture
Status
Organizational Units
Organizational Unit
Job Title
First Name
KAZıM
Last Name
KARAASLAN
Name
Email Address
Birth Date

Search Results

Now showing 1 - 5 of 5
  • PublicationOpen Access
    Usefulness of oxidative stress marker evaluation at admission to the intensive care unit in patients with COVID-19
    (2021-07-01T00:00:00Z) Daşkaya, Hayrettin; Yılmaz, Sinan; Uysal, Harun; Sümbül, Bilge; Karaaslan, Kazım; DAŞKAYA, HAYRETTİN; YILMAZ, SİNAN; UYSAL, HARUN; ÇALIM, MUHITTIN; SÜMBÜL, BİLGE; YURTSEVER, İSMAİL; KARAASLAN, KAZıM
    Objective:Two critical processes in the coronavirus disease 2019 (COVID-19) pandemic involve assessing patients- intensive care needs and predicting disease progression during patients- intensive care unit (ICU) stay. We aimed to evaluate oxidative stress marker status at ICU admission and ICU discharge status in patients with COVID-19.Methods:We included patients in a tertiary referral center ICU during June-December 2020. Scores of Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA), and clinical severity, radiologic scores, and healthy discharge status were noted. We collected peripheral blood samples at ICU admission to evaluate total antioxidants, total oxidants, catalase, and myeloperoxidase levels.Results:Thirty-one (24 male, 7 female) patients were included. At ICU admission, patients- mean APACHE II score at ICU admission was 17.61 ± 8.9; the mean SOFA score was 6.29 ± 3.16. There was no significant relationship between clinical severity and oxidative stress (OS) markers nor between radiological imaging and COVID-19 data classification and OS levels. Differences in OS levels between patients with healthy and exitus discharge status were not significant.Conclusions:We found no significant relationship between oxidative stress marker status in patients with COVID-19 at ICU admission and patients- ICU discharge status.
  • PublicationMetadata only
    Endoskopik ultrasonografi yapılan olgularda propofole ketamin veya fentanil ilavesinin sedo-analjezi kalitesi üzerine etkileri
    (2019-08-01T00:00:00Z) Daşkaya, Hayrettin; Uysal, Harun; Yılmaz İnal, Ferda; Esen, Asım; Karaaslan, Kazim; DAŞKAYA, HAYRETTİN; UYSAL, HARUN; ESEN, ASIM; KARAASLAN, KAZıM
  • PublicationMetadata only
    Gastro-laryngeal tube usage in ERCP sedo-analgesia cases
    (2014-06-02T00:00:00Z) Uysal, Harun; DAŞKAYA, HAYRETTİN; ÇİFTCİ, TANER; Baysal, Birol; İDİN, KADİR; KARAASLAN, KAZİM; DAŞKAYA, HAYRETTİN; UYSAL, HARUN; KARAASLAN, KAZıM
  • PublicationMetadata only
    Impact of the additive ketamine or fentanyl on quality ofsedation in endoscopic ultrasonography with propofol
    (2016-05-30T00:00:00Z) Uysal, Harun; DAŞKAYA, HAYRETTİN; YILMAZ İNAL, FERDA; ESEN, ASIM; KARAASLAN, KAZİM; DAŞKAYA, HAYRETTİN; UYSAL, HARUN; ESEN, ASIM; KARAASLAN, KAZıM
  • PublicationOpen Access
    The Effect of Exogenous Human Albumin Administration on Acute Kidney Injury Development in Hypoalbuminemic Patients in the Intensive Care Unit
    (2022-04-01T00:00:00Z) Yeşiltaş, Serdar; Güzel, Cumali; Sümer, İsmail; Uysal, Harun; Daşkaya, Hayrettin; Türkay, Meltem; Karaaslan, Kazım; YEŞİLTAŞ, SERDAR; SÜMER, İSMAİL; UYSAL, HARUN; DAŞKAYA, HAYRETTİN; KARAASLAN, KAZıM
    Objective: Hypoalbuminemia is an independent risk factor for acute kidney injury (AKI) and mortality. The primary aim of our study was to investigate the effect of exogenous human albumin (EHA) administration on hypoalbuminemic patients in the intensive care unit (ICU) regarding the development of AKI. Our secondary aim was to compare the ICU admission duration and mortality rates of these patients. Methods: After receiving ethics committee approval, the researchers retrospectively screened database for 5,989 patients admitted to the adult ICU from 01.01.2014 to 01.06.2018. The demographic data, serum albumin and creatinine levels, ICU admission duration and mortality rates of patients were recorded. Stage 2-3 AKI was accepted based on the AKI network criteria, while hypoalbuminemia was accepted as serum albumin values below 3.5 g/dL. Patients not given EHA were assigned to group none human albumin (Group NHA), while patients given EHA were assigned to group human albumin (Group HA). The rate of AKI development, duration of stay in ICU and mortality rates were compared between the groups. Results: The mean age, AKI development rate, mortality rate and ICU admission duration in Group HA were statistically significantly higher than in Group NHA (p=0.0001, p=0.0001, p=0.0001, p=0.0001). There was no difference in terms of the gender distribution in the groups. The mean albumin value in Group HA was statistically significantly lower than Group NHA (p=0.0001). Conclusion: In conclusion, EHA administration in hypoalbuminemic patients prolong stay in ICU in addition to the increase in the development of AKI and mortality.